D. C. Renswouw

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study

L. Brunsveld, M. Broeren, E. Schmitz, 2018, Alimentary pharmacology & therapeutics.